Biocept (BIOC) Financials

$0.07

$0.04 (125.16%)

As on 26-Dec-2023 09:30EDT

Market cap

$1 Mln

Revenue (TTM)

$-14 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	-14.39	25.86	61.25	27.46	5.53	3.25
Cost of Revenue	16.94	28.44	37.76	21.34	10.98	10.05
Gross Profit	-31.33	-2.58	23.49	6.12	-5.45	-6.80
Operating Expenses	21.87	29.40	25.89	21.59	17.61	17.46
Operating Profit (EBIT)	-48.90	-31.98	-2.41	-15.47	-23.06	-24.26
Other Income	--	--	--	-2.10	-1.83	--
Profit before Tax	-46.47	-32.21	-2.70	-17.81	-25.14	-24.57
Provision for Tax	-0.02	-0.13	0.13	-0.76	-0.52	0.00
Profit after Tax (Net Income)	-46.19	-32.09	-2.82	-17.04	-24.61	-24.57
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-12.69	--	-2.82	-17.81	-25.26	-25.21

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	0.29	8.86	37.48	23.69	11.20	3.04
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	16.91	16.51	11.16	11.26	0.97	1.10
Current Liabilities	4.90	5.51	11.77	12.49	5.56	4.61
Total Liabilities	27.01	30.87	60.42	47.45	17.73	8.75

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	13.24	14.53	14.73	14.86	3.84	2.74
Current Assets	8.86	16.34	45.69	32.59	13.89	6.01
Total Assets	27.01	30.87	60.42	47.45	17.73	8.75
Total Debt*	11.59	12.11	12.67	12.23	2.54	1.63
Net Current Assets	3.96	10.84	33.92	20.10	8.33	1.40

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-13.29	3.69	-19.79	-23.05	-22.36
Cash Flow from Investing Activities	--	--	-1.57	-0.87	-0.74	-0.15
Cash from Financing Activities	--	-1.87	12.38	25.72	29.66	23.78
Net Cash Inflow / Outflow	--	--	--	5.07	5.88	1.28

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-6.01	-1.88	-0.17	-38.13	-252.72	-1,595.56
Cash EPS ($)	--	-1.78	-0.01	-35.89	-244.78	-1,543.55
Adjusted Book Value ($)	--	0.52	2.22	53.02	115.00	197.57
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.78	0.22	-44.28	-236.65	-1,451.64
Free Cash Flow per Share ($)	--	-0.83	0.13	-46.22	-244.19	-1,461.07

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-90.23	-6.56	-68.63	-267.41	-565.32
ROE (%)	-1,009.57	-138.49	-9.23	-97.68	-345.64	-1,132.71
ROA (%)	-97.48	-70.30	-5.24	-52.29	-185.89	-304.68
EBIT Margin (%)	209.83	-123.69	-3.93	-56.33	-417.05	-746.35
Net Margin (%)	320.88	-124.09	-4.61	-67.20	-665.72	-755.98
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-125.69	-0.58	1.23	3.97	0.70	-0.36
EBIT Growth (%)	-185.16	-1,227.65	84.43	32.91	4.95	-14.56
Net Profit Growth (%)	-290.80	-1,036.23	83.43	30.76	-0.18	-13.69
EPS Growth (%)	-19.85	-10.22	1.00	0.85	0.84	0.73
Book Value Growth (%)	-85.41	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.28	-21.60	-0.12	0.00	0.00
Price / Book Value	0.37	1.02	1.63	0.08	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.34	-0.27	196.51	0.01	0.30	0.08
Close Price ($)	1.21	15.90	108.60	133.20	85.80	258.03
High Price ($)	36.00	120.60	251.40	390.00	1,116.00	7,380.00
Low Price ($)	1.13	13.80	97.80	63.36	68.25	197.40
Market Cap ($ Cr)	1.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	1.37	0.34	0.52	0.23	0.53
Short term debt to equity ratio	6.57	0.20	0.04	0.04	0.14	0.21
Current Ratio	1.81	2.97	3.88	2.61	2.50	1.30
Quick Ratio	1.70	2.83	3.66	2.45	2.36	1.18
Interest Coverage	-236.09	-101.21	-8.31	-6.61	-11.08	-78.01

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	-5.56	8.32	22.51	51.51	63.80	48.44
Asset Turnover	-0.30	0.57	1.14	0.84	0.42	0.40
Receivable days	--	112.56	83.28	117.52	168.51	155.51
Inventory Days	--	21.88	22.15	23.09	22.55	19.73
Payable days	--	56.31	75.49	88.82	67.40	60.13
Cash Conversion Cycle	--	78.13	29.94	51.80	123.66	115.11

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.